165 related articles for article (PubMed ID: 9225878)
21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
[TBL] [Abstract][Full Text] [Related]
23. [Value of the search for anticardiolipin antibodies during the course of systemic lupus erythematosus].
Gorgi Y; Ksouri H; Guermazii S; Ayed K; Dallagi K
Ann Med Interne (Paris); 1996; 147(8):531-5. PubMed ID: 9137678
[TBL] [Abstract][Full Text] [Related]
24. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
25. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
26. Association of nodular regenerative hyperplasia of the liver with porto-pulmonary hypertension in a patient with systemic lupus erythematosus.
Park YW; Woo H; Jeong YY; Lee JH; Park JJ; Lee SS
Lupus; 2006; 15(10):686-8. PubMed ID: 17120597
[TBL] [Abstract][Full Text] [Related]
27. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
28. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.
Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N
Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730
[TBL] [Abstract][Full Text] [Related]
29. The concomitant presence of lupus anticoagulant, anticardiolipin and anti-beta2-glycoprotein i antibodies could be associated with acquired activated protein c resistance in non-systemic lupus erythematosus patients.
Gennari L; Blanco A; Alberto MF; Grosso S; Lazzari MA
Br J Haematol; 2003 May; 121(3):527-9. PubMed ID: 12716380
[No Abstract] [Full Text] [Related]
30. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[TBL] [Abstract][Full Text] [Related]
31. Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus: three cases.
Leung VK; Loke TK; Luk IS; Ng WL; Chau TN; Law ST; Chan JC
Hong Kong Med J; 2009 Apr; 15(2):139-42. PubMed ID: 19342741
[TBL] [Abstract][Full Text] [Related]
32. [Association between antiphospholipid antibodies and arterial or venous thrombosis/thrombocytopenia].
Nojima J; Suehisa E; Kuratsune H; Amino N
Rinsho Byori; 1998 Dec; 46(12):1181-7. PubMed ID: 9916502
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus.
Bell PD; Thung S; Weiss S; Levstik M; Zhang D; Liu X; Liao X
Pathol Res Pract; 2020 Feb; 216(2):152770. PubMed ID: 31810588
[TBL] [Abstract][Full Text] [Related]
34. Vasculopathy and antiphospholipid antibodies in systemic lupus.
Piette JC; Frances C; Papo T; Karmochkine M
J Clin Pathol; 1993 Aug; 46(8):781-2. PubMed ID: 8408713
[No Abstract] [Full Text] [Related]
35. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
Romicka AM; Gazda A; Zabek J; Wojciechowska B
Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
[No Abstract] [Full Text] [Related]
36. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
37. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
38. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
[TBL] [Abstract][Full Text] [Related]
39. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
[TBL] [Abstract][Full Text] [Related]
40. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody.
Austin A; Campbell E; Lane P; Elias E
Gut; 2004 Jul; 53(7):1032-4. PubMed ID: 15194657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
